Filing Details
- Accession Number:
- 0001179110-15-012914
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-09-02 18:44:57
- Reporting Period:
- 2015-08-31
- Filing Date:
- 2015-09-02
- Accepted Time:
- 2015-09-02 18:44:57
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1113481 | Medicines Co | MDCO | Pharmaceutical Preparations (2834) | 043324394 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1277478 | Glenn Sblendorio | 8 Sylvan Way Parsippany NJ 07054 | President & Cfo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2015-08-31 | 266 | $24.74 | 99,805 | No | 4 | A | Direct | |
| Common Stock | Acquisiton | 2015-08-31 | 40,000 | $28.60 | 139,805 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2015-08-31 | 24,495 | $19.36 | 164,300 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2015-08-31 | 50,000 | $17.45 | 214,300 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2015-08-31 | 114,495 | $39.75 | 99,805 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | A | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right-to-buy) | Disposition | 2015-08-31 | 40,000 | $0.00 | 40,000 | $28.60 |
| Common Stock | Stock Option (right-to-buy) | Disposition | 2015-08-31 | 24,495 | $0.00 | 24,495 | $19.36 |
| Common Stock | Stock Option (right-to-buy) | Disposition | 2015-08-31 | 50,000 | $0.00 | 50,000 | $17.45 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2017-02-16 | No | 4 | M | Direct | |
| 0 | 2018-02-15 | No | 4 | M | Direct | |
| 15,000 | 2021-02-18 | No | 4 | M | Direct |
Footnotes
- Acquired pursuant to The Medicines Company Employee Stock Purchase Plan ("ESPP") for the ESPP purchase period beginning March 1, 2015 and ending August 31, 2015. In accordance with the terms of the ESPP, these shares were purchased based on 85% of the fair market value closing price of the issuer's common stock on March 2, 2015.
- Sales were effected pursuant to a Rule 10b5-1 program adopted by the reporting person.
- Represents the weighted average sales price of the shares sold ranging from a low of $39.03 to a high of $40.00 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- This option vested in forty-eight equal installments beginning on March 16, 2007.
- This option vested in forty-eight equal installments beginning on March 15, 2008.
- This option vested in forty-eight equal installments beginning on March 18, 2011.
- Not applicable.
Billionaire Hedge Funds
